These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9234520)

  • 1. Genetic to genomic vaccination.
    Johnston SA; Barry MA
    Vaccine; 1997 Jun; 15(8):808-9. PubMed ID: 9234520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccines.
    Lai WC; Bennett M
    Crit Rev Immunol; 1998; 18(5):449-84. PubMed ID: 9784969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression library immunization to discover and improve vaccine antigens.
    Barry MA; Howell DP; Andersson HA; Chen JL; Singh RA
    Immunol Rev; 2004 Jun; 199():68-83. PubMed ID: 15233727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivalent DNA-based vectors for DNA vaccine delivery.
    Roh YH; Lee K; Ye JJ; Luo D
    Methods Mol Biol; 2014; 1143():159-79. PubMed ID: 24715288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice.
    López-Fuertes L; Pérez-Jiménez E; Vila-Coro AJ; Sack F; Moreno S; Konig SA; Junghans C; Wittig B; Timón M; Esteban M
    Vaccine; 2002 Dec; 21(3-4):247-57. PubMed ID: 12450700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms for enhanced DNA vaccine immunogenicity.
    Li L; Petrovsky N
    Expert Rev Vaccines; 2016; 15(3):313-29. PubMed ID: 26707950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved vectors for expression library immunization--application to Mycoplasma hyopneumoniae infection in pigs.
    Moore RJ; Lenghaus C; Sheedy SA; Doran TJ
    Vaccine; 2001 Oct; 20(1-2):115-20. PubMed ID: 11567754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
    McNeilly CL; Beagley KW; Moore RJ; Haring V; Timms P; Hafner LM
    Vaccine; 2007 Mar; 25(14):2643-55. PubMed ID: 17239501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification by genomic immunization of a pool of DNA vaccine candidates that confer protective immunity in mice against Neisseria meningitidis serogroup B.
    Yero D; Pajón R; Pérez Y; Fariñas M; Cobas K; Diaz D; Solis RL; Acosta A; Brookes C; Taylor S; Gorringe A
    Vaccine; 2007 Jul; 25(28):5175-88. PubMed ID: 17544180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better protective effects in rhesus macaques by combining systemic and mucosal application of a dual component vector vaccine after rectal SHIV89.6P challenge compared to systemic vaccination alone.
    Stolte-Leeb N; Bieler K; Kostler J; Heeney J; Haaft PT; Suh YS; Hunsmann G; Stahl-Hennig C; Wagner R
    Viral Immunol; 2008 Jun; 21(2):235-46. PubMed ID: 18476770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal vaccination by DNA tattooing.
    van den Berg JH; Oosterhuis K; Schumacher TN; Haanen JB; Bins AD
    Methods Mol Biol; 2014; 1143():131-40. PubMed ID: 24715286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of improved vectors for DNA-based immunization and other gene therapy applications.
    Norman JA; Hobart P; Manthorpe M; Felgner P; Wheeler C
    Vaccine; 1997 Jun; 15(8):801-3. PubMed ID: 9234518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening the whole genome of a pathogen in vivo for individual protective antigens.
    Stemke-Hale K; Kaltenboeck B; DeGraves FJ; Sykes KF; Huang J; Bu CH; Johnston SA
    Vaccine; 2005 Apr; 23(23):3016-25. PubMed ID: 15811648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA pulsed macrophage-mediated cDNA expression library immunization in vaccine development.
    Manoutcharian K; Terrazas LI; Gevorkian G; Govezensky T
    Vaccine; 1999 Oct; 18(5-6):389-91. PubMed ID: 10519926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.
    Shata MT; Hone DM
    J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Molecular Design for a Hybrid Phage-DNA Construct Against DKK1.
    Khalili S; Rasaee MJ; Bamdad T; Mard-Soltani M; Asadi Ghalehni M; Jahangiri A; Pouriayevali MH; Aghasadeghi MR; Malaei F
    Mol Biotechnol; 2018 Nov; 60(11):833-842. PubMed ID: 30182325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective and therapeutic DNA vaccination against allergic diseases.
    Isakovic A; Weiss R; Thalhamer J; Scheiblhofer S
    Methods Mol Biol; 2014; 1143():243-58. PubMed ID: 24715292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
    Jiang H; Hu Y; Yang M; Liu H; Jiang G
    Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic live vaccines mimic the antigenicity but not pathogenicity of live viruses.
    Sykes KF; Johnston SA
    DNA Cell Biol; 1999 Jul; 18(7):521-31. PubMed ID: 10433551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the immune responses in BALB/c mice following immunization with DNA-based and live attenuated vaccines delivered via different routes.
    Cai MS; Deng SX; Li ML
    Vaccine; 2013 Feb; 31(9):1353-6. PubMed ID: 22995858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.